Please tell us about your experience of this website today

Mouse study identifies new target for human accelerated ageing syndrome

Mouse study identifies new target for human accelerated ageing syndrome

Scientists have identified a potential therapeutic target in the devastating genetic disease Hutchinson-Gilford progeria syndrome (HGPS), which is characterised by premature ageing.

The study – funded by the MRC, Wellcome and Cancer Research UK – provides preclinical data showing that chemical inhibition or genetic deregulation of the enzyme N-acetyltransferase 10 (NAT10) leads to significant health and lifespan gains in a mouse model of HGPS.

HGPS is a rare condition: patients have an average life expectancy of around 15 years, suffering a variety of symptoms including short stature, low body weight, hair loss, skin thickening, problems with fat storage, osteoporosis, and cardiovascular disease, typically dying of a heart attack.

Further Information